Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-127593
Filing Date
2021-10-19
Accepted
2021-10-19 16:26:46
Documents
2
Group Members
ALEC N. LITOWITZMAGNETAR CAPITAL PARTNERS LPSUPERNOVA MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2130573d1_sc13d.htm SC 13D 107319
2 EXHIBIT 99.1 tm2130573d1_ex99-1.htm EX-99.1 8016
  Complete submission text file 0001104659-21-127593.txt   117057
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88106 | Film No.: 211331404
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

EIN.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D